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doi:10.1016/j.jmb.2010.06.064Calreticulin (CRT) is an endoplasmic reticulum (ER) chaperone responsible
for glycoprotein folding and Ca2+ homeostasis. CRT also has extracellular
functions, e.g. tumor and apoptotic cell recognition and wound healing, but
the mechanism of CRT extracellular release is unknown. Cytosolic
localization of CRT is determined by signal peptide and subsequent
retrotranslocation of CRT into the cytoplasm. Here, we show that under
apoptotic stress conditions, the cytosolic concentration of CRT increases and
associates with phosphatidylserine (PS) in a Ca2+-dependent manner. PS
distribution is regulated by aminophospholipid translocase (APLT), which
maintains PS on the cytosolic side of the cell membrane. APLT is sensitive to
redox modifications of its SH groups by reactive nitrogen species. During
apoptosis, both CRT expression and the concentration of nitric oxide (NO)
increase. By using S-nitroso-L-cysteine-ethyl-ester, an intracellular NO donor
and inhibitor of APLT, we showed that PS and CRT externalization occurred
together in an S-nitrosothiol-dependent and caspase-independent manner.
Furthermore, the CRT and PS are relocated as punctate clusters on the cell
surface. Thus, CRT induced nitrosylation and its externalization with PS
could explain how CRT acts as a bridging molecule during apoptotic cell
clearance. © 2010 Elsevier Ltd. All rights reserved.Keywords: cell recognition; calreticulin–phosphatidylserine interaction;
endoplasmic reticulum; protein secretionEdited by J. KarnIntroduction
Calreticulin (CRT) is the most abundant calcium-
binding protein in the lumen of the endoplasmic
reticulum (ER) of all nucleated cells and is involved
in many intracellular and extracellular processes.1–3
In the ER, CRT has a number of functions, including
Ca2+ sensing, protein folding and a role inMHC class
I assembly.4 The multifunctional nature of CRT
suggests that it may be prevalent in many cellularess:
phospholipid
Fas ligand (CD95L);
, fluorescein
e isomerase; PC,
ylserine; ROS,
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al., A Mechanism of Releasecompartments. Recent work has explained, in part,
how CRT translocates from the ER to the cytosol,5
where it undergoes arginylation.6 During cell stress,
both CRT expression and the concentration of nitric
oxide (NO) increase and CRT is released from cells
by unknown mechanisms.7,8 Immunological evi-
dence that CRT is released from cells comes from a
number of autoimmune conditions that present with
CRT autoantibodies.9,10 Cell surface expression of
CRTmight require post-translationalmodification of
the protein, e.g. cleavage of its C-terminal KDEL-
based ER retrieval sequence, or CRT interaction with
other proteins that mask the retrieval sequence. In
support of this hypothesis, a number of truncated
forms of CRT have been found that might explain
how CRT leaves the cell.11 Proteolysis studies have
shown that the NH2-terminal half of CRT lacking
the KDEL sequence is resistant to proteolysis in
the presence of physiological concentrations of
Ca2+.12,13 The ER is a site of reactive oxygen species
(ROS) production, but has few anti-oxidant defenses.d.
of Calreticulin from Cells During Apoptosis, J. Mol. Biol. (2010),
2 Mechanisms of CRT Release from Cells Under StressDuring cell stress, CRT is susceptible to oxidative
modifications, such as carbonylation, which might
affect its retention in the ER.14 CRT acts as a Ca2+
store in the ER. The translocation of CRT to the
cytosol or extracellular environment might influence
the process of apoptosis that is regulated by free
Ca2+. The importance of CRT in apoptotic regulation
of cell death is supported by the observation that
CRT-deficient cells are more resistant to apoptosis
than cells induced to over-express CRT.15
The relevance of extracellular CRT in human health
and disease is substantial. Recent studies have shown
that CRT plays a major role in tumor recognition,
wound healing and enhancing the clearance of
apoptotic cell debris.16–18 Our studies have shown
that patientswith autoimmunediseases have a greater
accumulation of CRT in their circulation, indicating an
increased release of CRT during cell stress.19
The current study provides evidence of the
redistribution of CRT within human Jurkat T cells
during stress conditions, as occurs during apoptosis.
We demonstrate that CRT is present on the surface of
both pre-apoptotic and Fas (CD95)-mediated apo-
ptotic cells to varying degrees. Stimulation of CD95
with soluble Fas ligand (FasL or CD95L) is known to
lead to receptor aggregationwithin PS-enriched lipid
rafts, in association with Fas-associated death
domain-containing protein (FADD). FADD can
interact with procaspase-8, forming the multi-pro-
tein death-inducing signaling complex (DISC),
which drives cells towards apoptosis.20 Earlier, we
showed that CRT is associated with lipid rafts,21 and
can interact with FasL to prevent CD95-mediated
apoptotic death in Jurkat T cells.22 In this study we
show that CRT binds predominantly to PS in a Ca2+-
dependent manner. The release of CRT occurs in
concert with PS externalization in a caspase 3-
independent manner upon transnitrosylation of
aminophospholipid translocase (APLT) by S-nitro-
sothiols. Our novel results explain how CRT can be
released in a regulated manner from cells undergo-
ing nitrosative stress via S-nitrosylation/oxidation
of the SH groups of APLT by intracellular NO
released from an NO donor. The inhibition of APLT
leads to PS externalization in association with CRT.
Given the importance of extracellular CRT for tumor
and apoptotic cell recognition and wound healing,
the ability to manipulate the release of CRT in a non-
caspase-dependent manner might have important
implications for the resolution of inflammation.Results
Presence of plasma membrane-associated
CRT and its release from resting and
apoptotic cells
CRT has been reported on the surface of various
eukaryotic cells.4 Initially, we investigated whether
CRT is expressed non-specifically together with
other ER proteins on the extracellular surface ofPlease cite this article as: Tarr, J. M., et al., A Mechanism of Release
doi:10.1016/j.jmb.2010.06.064Jurkat T cells. Untreated and apoptotic (treated with
25 ng/ml FasL) cells were labeled with biotin for the
purpose of isolating membrane proteins. Equal
amounts (30 μg) of biotin-labeled plasma membrane
(PM) proteins and total cell lysates, as determined by
nanodrop spectrophotometry, were transferred onto
a number of polyvinylidene fluoride membranes
(Fig. 1a). Control blots were probed with anti-biotin-
HRP to ensure equal loading (Fig. 1a, right-hand
panel). In addition, as HSP70 is known to be present
in the cytosol and PM of cells, anti-HSP70 was used
to check for equal sample transfer of PM and cell
lysate (CL) preparations onto the immunoblots.
Then blots were immunoblotted with antibodies
against the ER proteins CRT, calnexin, protein
disulfide isomerase (PDI) and KDEL peptide. As
shown in Fig. 1a (lower panels), the anti-calnexin
antibody produced a strong band at 90 kDa (pre-
dicted molecular mass) in the CL. The anti-KDEL
antibody produced bands at 78 kDa and 94 kDa (the
predictedmolecularmass of BIP (GRP78) andHSP90
(GRP94), respectively). The PDI antiserumdetected a
single protein of approximately 60 kDa. Immuno-
blotting with α-CRT identified a single 60 kDa band
indicative of CRT on the PMs of apoptotic Jurkat cells
but not resting cells (Fig. 1a, lanes 2 and 1,
respectively) and in whole cell lysates from resting
and FasL-treated Jurkat cells (Fig. 1a, lanes 3 and 4).
Further experiments confirmed that Jurkat cells did
not have the ER proteins calnexin or PDI on their cell
surface. The KDEL antibody did not recognize CRT
on the PM, indicating that a KDEL sequence is not
exposed, possibly because of steric hindrance or
because the KDEL sequence was not present on CRT
at the cell surface. A final blot was probed with α-
biotin to confirm that multiple biotinylated PM
proteins had been extracted (Fig. 1a right-hand
panel). To confirm that CRT is predominantly
present on Jurkat cells during apoptotic stress, the
surface expression of CRT on intact cells was assessed
by flow cytometry. Approximately 8.5% of untreated
Jurkat cells were undergoing spontaneous apoptosis
(as determined by annexin V staining and size) at any
given time under the culture conditions used (Fig 1b,
top left panel). These cells appeared smaller (7–8 μm
diameter) compared with the non-apoptotic cells
(9–13 μm diameter). The same population of cells
expressed CRT on their cell surface (Fig 1b, top
middle and right-hand panels). After treatment
with FasL for 4 h, 24% of the Jurkat cells were
assessed by annexin V staining as apoptotic, while
44% of the cells exhibited CRT on their cell surface
(Fig 1b, bottom, middle and right-hand panels).
Immunoblots were used to monitor the release of
CRT from Jurkat cells into the cell medium with
and without treatment with digitonin. The appli-
cation of digitonin at concentrations ≤50 μg/ml
permeabilizes the plasma membrane of cells,
leaving cytosolic organelles intact, while the use
of a higher concentration of digitonin (500 μg/ml)
solubilizes the remaining membrane-bound orga-
nelles. Only weak bands were apparent for the
release of CRT from resting Jurkat cells (Fig. 2a,of Calreticulin from Cells During Apoptosis, J. Mol. Biol. (2010),
Fig. 1. Detection of CRT on the plasma membrane of Jurkat T cells (JKT). (a) Immunoblots were prepared of isolated
biotinylated plasma membrane (PM) proteins from untreated (lane 1) and FasL-treated (lane 2) Jurkat cells. Equal gel
loading was demonstrated by probing the PM blots with α-biotin and α-HSP70. Biotin-labeled PM extracts were probed
with α-human CRT, calnexin, PDI and KDEL. Control cell lysate (CL) preparations of untreated and FasL-treated cells
confirmed each of the ER protein antibodies used to detect their specific intracellular proteins calnexin, KDEL and PDI
(middle panel). Markers of 50–120 kDa are shown for the top panel.Markers for 20–120 kDa are shown for the lower panel.
(b) Flow cytometric analysis of apoptotic Jurkat cells and surface CRT expression. Dot plots show the percentage of cells
undergoing apoptosis under resting and FasL-treated conditions. Cells positive for annexin V staining and CRT surface
expression are shown (pink) together with non-annexin V staining and CRT negatve expressing cells (black). The
immunoblots and flow cytometric analysis are representative of three experiments.
3Mechanisms of CRT Release from Cells Under Stresslane 2), indicative of a small but detectable amount
of CRT being released into the medium. This was
marginally increased upon treatment with FasL
(Fig 2a, lane 3). Cytosolic proteins can be released
and tracked more readily by treating cells with
50 μg/ml of digitonin.23 The protein released into
Ca2+-free cell medium from the equal cell numbers,
pre- and post-digitonin treatment with and withoutPlease cite this article as: Tarr, J. M., et al., A Mechanism of Release
doi:10.1016/j.jmb.2010.06.064FasL was assessed by SDS-PAGE followed by
immunoblotting with anti-calnexin or anti-CRT.
The intracellular location of CRT (Fig. 2a) and
calnexin (Fig. 2c) during FasL-induced apoptotic
stress in Jurkat cells was tracked by treating cells
with digitonin and the amounts of CRT released
were monitored by densitometry (Fig. 2b). To
prevent the released protein binding to the plasmaof Calreticulin from Cells During Apoptosis, J. Mol. Biol. (2010),
Fig. 2. Extracellular release
under resting and apoptotic condi-
tions and intra and extracellular
location of CRT from digitonin
treated cells. (a) Immunoblot anal-
ysis of spontaneous and digitonin
release of CRT from cytosolic pools
and total intracellular stores of
1×107Jurkat cells (left-hand panel,
lane 1 depicts western markers).
Lanes 2, 4 and 6 represent CRT
released from resting cells treated
with 0, 50 and 500 μg/ml digito-
nin, respectively. Lanes 3, 5 and 7
represent cells treated with 25 ng/
ml FasL for 4 h and treated with 0,
50 and 500 μg/ml digitonin, re-
spectively. (b). A densitometry plot
depicts the relative differences in
release of CRT into the medium in
comparison with (c) known
amounts of CRT. (d) Calnexin
release from Jurkat cells after digitonin treatment as described for a. The immunoblots are representative of three
experiments.
4 Mechanisms of CRT Release from Cells Under Stressmembrane of cell lysates in a Ca2+-dependent
manner, treatment with digitonin was done in the
presence of 0.5 mM EGTA. As a positive control of
protein release from cytosolic organelles, we used aFig. 3. Synthesis, analysis and release of nitric oxide from
prepared by direct S-nitrosation of the hydrochloride of L-cyst
analysis was performed to check the purity and chemical com
spectrum demonstrating the release of nitric oxide (NO) from
decomposed in the presence of the N-methyl-D-glucamine dit
NO released was spin trapped with (MGD)2-Fe
2+ as described
signal (g=2.04 and aN=1.28 mT). The spectrum was obtained
acquisition parameters: microwave frequency, 9.43 GHz; micr
4 mT; time constant 1s; sweep time, 80s; modulation frequenc
Please cite this article as: Tarr, J. M., et al., A Mechanism of Release
doi:10.1016/j.jmb.2010.06.064higher concentration of digitonin (500 μg/ml) to
permeabilize and solubilize all the internal mem-
branes of the cells. This demonstrated the addi-
tional release of non-cytoplasmic sources of CRTS-nitroso-L-cysteine ethyl ester (SNCEE). (a) SNCEE was
eine ethyl ester (CEE.HCl) with ethyl nitrite. (b) Elemental
position of SNCEE. (c) Electron paramagnetic resonance
the synthesised product, SNCEE. Synthesized SNCEE was
hiocarbamate (MGD)-Fe2+ complex at alkaline pH and the
.59 The spectrum shows a typical NO-(MGD)2-Fe
2+ triplet
with a JEOL JES RE1X spectrometer with the following
owave power, 4 mW; centre field, 331.3 mT; sweep width,
y, 100 kHz and modulation width, 0.1 mT.
of Calreticulin from Cells During Apoptosis, J. Mol. Biol. (2010),
5Mechanisms of CRT Release from Cells Under Stress(Fig. 2a and b) and the release of the membrane-
bound ER protein calnexin (Fig. 2c). Treatment of
cells with 50 μg/ml or 500 μg/ml of digitonin
increased the release of CRT from the cytosolic pool
and ER pools of untreated and FasL-treated cells,
respectively. Interestingly, the relative molecular
mass of CRT released from Jurkat cells was ∼3–
5 kDa smaller than that of the CRT present in the
ER of FasL-stimulated cells. Calnexin was not
detected in untreated cells or in cells treated with
50 μg/ml of digitonin, confirming the lack of
penetration of the ER by digitonin at this lower
concentration.
Interaction of CRT with phosphatidylserine (PS)
and release upon PS externalization
We next hypothesized that CRT release might be
increased during necrosis via breakdown of mem-
brane integrity. Alternatively, PS might be involvedFig. 4. PS externalization on the surface of Jurkat cells ex
presence of CRT on the cell surface. (a) Flow cytometric anal
externalization (annexin V-positivity) on the surface of Jurkat
DTT. The asterisk (⁎) indicates a significant increase (pb0.05) in
Cells were treated with SNCEE for 30 min at 37 °C, washed an
vehicle control for SNCEE. (b) Demonstration of PS externaliz
and without DTT (5 mM) as detected by annexin V-positivity
with PS externalization induced by treatment with SNCEE o
manner, respectively (⁎pb0.05, FasL versus control, Mann–Wh
positivity) in Jurkat cells treated with 600 μM SNCEE with and
represents cells without SNCEE treatment or FasL stimulatio
versus control, Mann–Whitney U test. The value of each bar r
Please cite this article as: Tarr, J. M., et al., A Mechanism of Release
doi:10.1016/j.jmb.2010.06.064in CRT release during PS externalization onto the
outer surface of the PM during apoptosis. To
address this, we studied the regulation of PS
externalization by APLT. Experiments were done
in which PS was induced to flip to the external side
of the membrane without provoking a caspase 3-
dependent apoptotic event. We synthesized the NO-
producing transnitrosylating agent S-nitroso-L-cys-
teine ethyl ester (SNCEE) as described (Fig. 3a).24
The composition and purity of the compound (Fig.
3b) were checked independently by elemental
analysis (Elemental Microanalysis Ltd, Devon,
UK). SNCEE enters cells rapidly and its ability to
generate NO was determined by electron paramag-
netic resonance as described,25 in which the typical
NO triplet peak was observed as shown in Fig. 3c.
APLT is sensitive to oxidation of its sulfhydryl
groups by SNCEE.26 In earlier studies, SNCEE was
shown to inhibit APLT activity directly and to
increase scramblase activity threefold,27 leading toposed to the transnitrosylating agent SNCEE leads to the
ysis of the concentration response effect of SNCEE on PS
cells and the ability to reverse the effect in the presence of
annexin V binding compared with untreated control cells.
d then stained with annexin V directly. Ethanol acted as a
ation by 600 μM SNCEE and 25 ng/ml FasL, or both, with
by flow cytometry. (c) Translocation of CRT in association
r FasL occurred in a caspase 3-independent or dependent
itney U test). (d) Extracellular CRT expression (anti-CRT
without 5 mM DTT or 25 ng/ml FasL. The control group
n. ⁎pb0.05, FasL versus control, SNCEE treatment±DTT
epresents the mean±SD of three experiments.
of Calreticulin from Cells During Apoptosis, J. Mol. Biol. (2010),
6 Mechanisms of CRT Release from Cells Under StressPS externalization. We used flow cytometry to
quantify the numbers of cells with external PS and
CRT after treatment of Jurkat cells with SNCEE.
Cells treated with of 75–1200 μM SNCEE led to a
sequential and statistically significant increase in
extracellular PS as detected by annexin V staining
(Fig. 4a). Treatment of Jurkat cells with 600 μM
SNCEE for 30 min was optimal for increasing the
numbers of cells positive for surface PS by up to
fourfold (Fig. 4b). To ascertain if the increase in
external PS was due to S-nitrosylation of APLT in
cells, experiments were done in the presence of the
de-nitrosylating agent dithiothreitol (DTT), which
was shown to reverse SNCEE-induced inhibition of
APLT as indicated by the 50% reduction in external
PS expression. Jurkat cells were treated with FasL
for 4 h at 37 °C leading to a threefold increase in cells
positive for external PS, which was not inhibited by
treatment with DTT. This was expected, because
FasL-induced apoptosis is caspase 3-dependent
when the denitrosylated form of the enzyme is
active;28 therefore, DDT would be expected to
enhance, not inhibit, the denitrosylation of caspase
from its inactive S-nitrosylated state. We confirmed
that cells exposed to SNCEE externalize PS in a
caspase 3-independent manner (Fig. 4c). In contrast,
FasL-induced apoptosis and PS externalization wasshows cells treated with SNCEE (600 μM) and DTT (5 mM) sim
20 μm.
Please cite this article as: Tarr, J. M., et al., A Mechanism of Release
doi:10.1016/j.jmb.2010.06.064caspase 3-dependent. CRT surface expression oc-
curred in parallel with PS exposure in cells treated
with SNCEE or Fas-L, demonstrating that the
protein is clearly associated with PS surface expres-
sion irrespective of the mechanism of PS external-
ization (Fig. 4d). To exclude the possibility that CRT
was not released from the cytosol and then attached
to the cell-surface proteins rather than being
transferred to the cell surface with PS, we did
additional experiments on adherent HeLa cells
transiently transfected with green fluorescent pro-
tein (GFP)-CRT. As shown in Fig. 5a, GFP-CRT
transfected into HeLa cells was predominantly
translocated to the ER, as confirmed employing a
specific ER marker (ER-Tracker Blue DPX dye). As
expected, GFP-CRT localized to distinct ER apopto-
tic blebs following treatment with H2O2 (Fig. 5b).
The visual effect of SNCEE on externalization of PS
and GFP-CRT is shown in Fig. 5c where, as
expected, some untreated cells (possibly undergoing
spontaneous apoptosis) showed patches of annexin
V binding (red) on a few cells. In response to
SNCEE, there was greater evidence of PS external-
ization on both GFP-CRT transfected and non-
transfected cells. Both GFP-CRT and annexin V
formed patches of fluorescence on the surface of
SNCEE-treated HeLa cells. Importantly, GFP-CRTFig. 5. Location of CRT in HeLa
cells under resting, apoptotic and
SNCEE-treated conditions. (a) GFP-
CRT proteins were efficiently tar-
geted to the ER of HeLa cells. Cells
were transiently transfected with
full-length CRT and counterstained
using ER-tracker (ER blue) and
nucleoli were stained with ethi-
dium bromide (red) under physio-
logical conditions. (b) Subcellular
localization of CRT during H2O2
-induced apoptosis. Targeting to
apoptotic ER stress granules was
monitored in HeLa cells expressing
GFP-CRT after exposure to 1 mM
H2O2 for 6 h. Nuclei were counter-
stained using DAPI (blue) to assess
nuclear fragmentation. (c) PS exter-
nalization on the surface of HeLa
cells exposed to SNCEE. The top
panel shows three representative
images of untreated HeLa cells
transfected with GFP-CRT and
counterstained with annexin V
(red) and DAPI (blue). The white
arrows show non-transfected cells.
The middle panel shows three
representative images of HeLa
cells treated with SNCEE (600 μM)
for 30 min at 37 °C. The yellow
arrows show externalization of
CRT, where it is retained on the
same cells in punctate raft-like
aggregates. The bottom panel
ultaneously for 30 min at 37 °C. The scale bar represents
of Calreticulin from Cells During Apoptosis, J. Mol. Biol. (2010),
7Mechanisms of CRT Release from Cells Under Stresswas not observed to be released and bind to
neighboring non-transfected cells despite the pres-
ence of external PS on the surface of non-transfected
cells (Fig. 5c middle panels; white and yellow
arrows). The treatment of HeLa cells with SNCEE
and DTT prevented externalization of GFP-CRT and
PS (Fig 5c, low panels).
The ability of CRT, which is highly negatively
charged (pI 4.46), to interact specifically with
negatively charged PS has not been reported. ToFig. 6. Demonstration of CRT binding to PS-containing lip
The presence of PS on the external surface of liposomes was de
binding to liposomes consisting of 100% PC or 70% PC and
fluorescence plot showing the percentage of liposomes (70% PC
quadrant), percentage positive for CRT binding alone (upper
annexin V binding (upper right quadrant). (d) Phase and immu
diameter 11 μm) incubated with annexin V-PE and CRT-FITC
images). ⁎pb0.05, PS and PC versus PC only liposomes, mean
Please cite this article as: Tarr, J. M., et al., A Mechanism of Release
doi:10.1016/j.jmb.2010.06.064determine if the interaction of CRT with cell
phospholipids was due to direct binding to PS, full-
length, N-C and P domains of CRT conjugated with
fluorescein isothiocyanate (FITC) and annexin V
conjugated to phycoerythrin (PE) were incubated
with the neutrally charged phosphatidylcholine (PC)
and PC/PS-containing liposomes, then analyzed by
flow cytometry. In the presence of Ca2+, annexin V
bound to approximately 55% of PS-containing
liposomes (Fig. 6a) but bound to b10% of PC-onlyosomes by flow cytometry and immunofluorescence. (a)
termined by direct binding to annexin V-PE. (b) CRT-FITC
30% PS was detected by flow cytometry. (c) A double-
, 30% PS) positive for annexin V binding alone (lower right
left quadrant) and percentage positive for both CRT and
noflourescent images of 70% PC, 30% PS liposomes (mean
showing the colocalization of CRT binding to PS (merged
±SD, Mann–Whitney U test, n=3.
of Calreticulin from Cells During Apoptosis, J. Mol. Biol. (2010),
Fig. 7. CRT binding to PS is Ca2+-dependent. Lipo-
somes comprised of 30% PS and 70% PC were prepared
and suspended in buffer supplemented with 2.5 mM Ca2+
or 5 mM EGTA. The binding of annexin V-PE or CRT-
FITC was assessed by flow cytometry. In the presence of
Ca2+, annexin V bound specifically to about 35% of the PS-
PC liposomes. However, in depleted Ca2+ buffer, annexin
V was bound to 80% of the liposomes, because in the
presence of low concentrations of Ca2+ annexin V binds to
PC non-specifically:⁎pb0.05, calcium versus EGTA, mean
±SD, Mann–Whitney U test, n=3). In contrast, CRT was
bound to approximately 30% of PS-containing liposomes
in the presence of 2.5 mMCa2+ but to only about 5% in the
presence of EGTA: ⁎pb0.05, Ca2+ versus EGTA, mean±SD,
Mann–Whitney U test, n=3).
8 Mechanisms of CRT Release from Cells Under Stressliposomes. The same liposomes were incubated with
0.2 mM and 2 mM CRT-FITC and both bound to
statistically significantly more PS-containing lipo-
somes than PC-alone liposomes (Fig. 6b). Liposomes
exposed to annexin V-PE and CRT-FITC simulta-
neously were assessed for binding by dot plot
analysis (Fig. 6c), which demonstrated that approx-
imately 50% of PS-containing liposomes positive for
annexin V were positive also for CRT. Representa-
tive visible light and fluorescent micrographs of PC/
PS liposomes are shown in Fig. 6d. Liposomes
composed of 70% PC, 30% PS bound annexin V
(red) and full-length CRT (green) in a colocalized
manner, as evident from the merged images that
appeared yellow. The distribution of the proteins
appeared to occur in a patched or aggregated array
up to several micrometers across. Interestingly the
N-C and P domains of CRT bound very poorly, with
5% of PS-containing liposomes staining positive for
either CRT domain (data not shown). In control
experiments, FITC-BSA, IgG-FITC or FITC alone did
not bind to liposomes directly. In contrast, FITC-CRT
or its domains failed to bind to liposomes composed
of only phosphatidylcholine. Nominal amounts of
annexin V-PE bound to PC-only liposomes (Fig. 6a).
The binding of CRT to PS was determined to be
Ca2+-dependent and could be inhibited in the
presence of 5 mM EGTA (Fig. 7).Discussion
Extracellular CRT is important for essential
physiological functions, such as assisting in thePlease cite this article as: Tarr, J. M., et al., A Mechanism of Release
doi:10.1016/j.jmb.2010.06.064recognition of apoptotic cells29–31 and opsonizing
tumor cells for engulfment by antigen-presenting
cells.18 Therefore, it is important to explain how CRT
is released from cells under various conditions,
including cell stress. A number of studies have now
begun to explain how CRT might move between
organelles.32,33 A recent study suggested CRT retro-
translocates from the ER to the cytosol via the
nucleus.34 Once in the nucleus, CRT is free to
interact with proteins with nuclear export signals
(NES) and then move into the cytosol, where CRT
can be post-translationally modified by incorpora-
tion of arginine into the protein in a Ca2+-dependent
manner via arginyl transferase activity.6 Such
modifications, as well as cleavage by proteases,
might explain why under certain conditions CRT
cannot be detected by standard immunochemistry
techniques, e.g. immunoblotting and flow cytome-
try. Modified forms of the protein in the cytosol or
on the extracellular side of the PM might not be
recognized by antibodies raised against the non-
post-translationally modified protein or might ap-
pear to migrate on SDS-PAGE at different relative
molecular masses. In this study, it was interesting to
note a relative 4–5 kDa difference in molecular mass
of CRT extracted from the ER compared with the
cytosolic and extracellular forms of CRT. Earlier, we
showed that CRT is susceptible to proteolytic
cleavage dependent on the concentration of Ca2+,12
which generates fragments with various molecular
masses. Others have detected modified forms of
CRT with a reduced relative molecular mass of
6 kDa, lacking the KDEL C-terminal sequence, and
suggest this might alter the ability of CRT to be
retained in the ER.11 In other studies, ‘ecto-forms’ of
CRT have been found that migrate in SDS-PAGE
consistent with a molecular mass approximately
6 kDa greater than that of 58–60 kDa reported here
and by most other studies. Clearly, post-translation
modifications of CRT either in the ER or after its
translocation to other cellular sites, such as arginyla-
tion of CRT in the cytosol, could alter the folding
structure or charge of the protein.6
In our cell-surface biotinylation immunoblot
studies, exoforms of CRT were detected more
readily on the surface of FasL-treated apoptotic
Jurkat cells. (Fig. 1a). This was confirmed by analysis
by flow cytometry, where 24% of the apoptotic cells
(as assessed by annexin V) were also positive for cell-
surface CRT. However, 44% of cells were positive for
CRT, which suggests that a proportion of the surface
expression of CRT occurs before apoptosis, as
suggested by Obeid,35 but that additional CRT is
released upon PS externalization. Alternatively, the
presence of surface-bound CRT on this subpopula-
tion of Jurkat cells staining negative for annexin V
might be as a requirement or action of the many
other extracellular physiological roles of CRT.
The retrotranslocation of CRT from the ER to the
cytosol is well established.5 In this study, activation
of the extrinsic pathways (FasL) of apoptosis
resulted in the detection of increased cytosolic CRT
in Jurkat cells (Fig. 2a and b). The cell has tightof Calreticulin from Cells During Apoptosis, J. Mol. Biol. (2010),
9Mechanisms of CRT Release from Cells Under Stresscontrol over apoptosis and is regulated by activation
of Ca2+-dependent enzymes.36 Within the cytosolic
environment, CRT acts as a Ca2+ buffer controlling
the local release of Ca2+. Importantly, cytosolic Ca2+
is involved in the regulation of the amount of PS
found on the inner (80% PS) and outer (20% PS)
surfaces of the plasma membrane of healthy cells.37
An intriguing result of this study is the demonstra-
tion that CRT binds directly to PS in a Ca2+-
dependent manner (Fig. 7), where it might provide
Ca2+ locally to help regulate the amount of PS on the
extracellular leaflet, which acts as an ‘eat me’
signal.38 Both CRT and PS formed punctae at sites
of contact with each other in liposomes, which we
have seen with CRT on the surface of neutrophils.16
This infers CRT can form large oligomers at the cell
surface possibly in association with other proteins
and clusters of PS. These observations are indicative
of CRT clustering in lipid rafts, which we have
recently confirmed appears to be the case in mouse
lymphoma cells.21 In this study, we saw similar
surface aggregates in SNCEE-treated HeLa cells
transiently expressing GFP-CRT (Fig. 5c, middle
panel). Moreover, it is established that Fas/FasL
translocate to lipid rafts in T cells upon activation.39
We have demonstrated also that extracellular CRT
inhibited Fas/FasL interactions on Jurkat T lym-
phocytes. This could explain, in part, how CRT
imparts T cell resistance to apoptosis by associating
with key apoptotic signaling proteins that are
concentrated in these lipid rafts.22 Interestingly,
phosphatidylserine is highly enriched in such rafts
and might stabilize raft formation.40 Co-capping
and co-localization studies have demonstrated that
phosphatidylserine is present on the outer surface of
rafts in activated lymphocytes.41 The suggestion
that CRT can down -regulate apoptotic signaling is
not novel. Recently, thrombospondin 1 enhance-
ment of CRT/LDL receptor-related protein complex
formation has been shown to signal resistance of
fibroblasts to apoptosis due to loss of cell adhesion
(anoikis).42
It is possible that surface CRT is secreted by an
unknown mechanism and re-associated with the
plasma membrane, rather than flipped through our
proposed mechanism. We investigated this possi-
bility using GFP-CRT immunofluorescence (Fig. 5).
Representative images that contain transfected cells
surrounded by several non-transfected ones are
shown in Fig. 5. If the transiently expressed GFP-
protein was secreted, we argue that it would be
seen on the surface of both the transfected cells and
the surrounding non-transfected cells. As shown in
Fig. 5c, this is not the case, with GFP-CRT restricted
to the surface of transfected cells only. We believe
this demonstrates that CRT is not simply secreted,
but that it is released in a more controlled manner,
and that our proposed flipping could, in principle,
account for this process. However, this does not
exclude the possibility that CRT is translocated to the
cell surface by other mechanisms under different
physiological conditions.Wedid observe a change in
the morphology of the SNCEE-treated cells and thisPlease cite this article as: Tarr, J. M., et al., A Mechanism of Release
doi:10.1016/j.jmb.2010.06.064might indicate S-nitrosylation of some of the cell
cytoskeleton proteins, as reported earlier.43
We investigated the role of calcium ions in the
CRT–PS interaction. It has been known for a number
of years that Ca2+ binds directly to PS, inducing the
formation of PS aggregates.44 Therefore, it is possible
that the colocalization of CRT and annexin Vmay be
due to annexin V binding directly to PS, while
negatively charged regions of CRT bind electrostat-
ically via Ca2+, to the same aggregates. Alternatively,
it has been calculated that the 36 kDa annexin V
molecule binds to both PC/PS vesicles and cells with
a similar stoichiometry in which 40 PS molecules are
required to bind to a single annexin V molecule in a
Ca2+-dependent manner.45 In our study, CRT
binding to PS is Ca2+-dependent and is inhibited
by EGTA (Fig. 7). The co-localization of CRT and
annexin V binding to PS as observed in Fig. 6d can be
explained by CRT and annexin V binding in close
proximity to different PS molecules adjacent to one
another, particularly as annexin V binding and CRT
binding to PS-containing liposomes never attained
100% binding under our experimental conditions
(Fig. 6a and b).
The externalization of PS is dependent on the
ATP-dependent APLT and inactivation of APLT
causes egress of PS from the inner to the outer leaflet
of the PM.46 The inner leaflet of the PM is
predominantly negatively charged 47 and comprises
10–30% of PS. It has been shown that pools of PS on
the cytosolic side of the cell can serve to dock basic
proteins with binding to C2 domains.48 CRT would
not normally be expected to associate non-specifi-
cally with negatively charged PS, as CRT is an acidic
protein with high negative charge. However, the
globular head contains clusters of amino acids that
are hydrophobic and basic in nature and could act as
a ‘docking’ region to PS. However, in this study we
did not see preferential binding of the N-C domain
(globular head) region of CRT compared with the P
domain, suggesting the intact protein is required for
binding to PS. A study by Obeid et al. demonstrated
that CRT appeared on the surface of tumor cells,
before apoptosis, upon exposure to anthracycline
drugs and ultraviolet C light.18
It has been suggested that CRT and ERP57, which
associate in the ER, might translocate together in the
same molecular complex.35 Human CRT is not
glycosylated,12 but a recent study investigated the
signal mechanisms for release of mutant glycosy-
lated forms of recombinant CRT upon exposure to
anti-tumor drugs.49 These artificial N-glycosylated
mutant CRT species appeared to be exocytosed
through a Soluble NSF Attachment Protein
(SNARE)-dependent pathway, suggesting glycosy-
lated CRT, if it existed, would traffic through a
conventional secretory pathway in which exocytic
vesicles have to fusewith the plasmamembrane. The
assembly of SNARE complexes to allow vesicles to
contact the inner layer of the cell membrane and
allow their fusion is dependent on local levels of Ca2+
and, again, CRT might act as a Ca2+ buffer during
this process. The trafficking of CRT by the secretoryof Calreticulin from Cells During Apoptosis, J. Mol. Biol. (2010),
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cytosol would bring CRT into close proximity with
the inner leaflet of the plasma membrane in close
association with PS. Using a novel system, we tested
if the outward flipping of PS led to the surface
expression of CRT, independent of caspase 3
activation and apoptosis. We used the transnitrosa-
tion reagent SNCEE which is known to inhibit the
activity of the PS externalization regulatory enzyme
APLT and activate scramblase by enhanced modi-
fication of one or more SH groups.50 We observed
elevated PS externalization and CRT surface expres-
sion in a caspase 3-independent manner (Fig. 4c).
Both CRT and PS extracellular expression were
reversed with DTT (Fig. 4), presumably because
DTT can de-nitrosylate S-nitrosylated proteins in
live cells and might contribute to rejuvenating APLT
activity.51 In contrast, the induction of FasL-induced
apoptosis caused PS and CRT externalization (Fig.
4b and d) in a caspase 3-dependent manner (Fig. 4c).
Taken together, these observations argue that
nitrosative stress can regulate PS externalization
and CRT release by inhibiting APLT. However,
scramblases are also thought to influence PS
externalization. The general dogma for externaliza-
tion of PS on the outer membrane is for APLT
inhibition to occur together with activation of
phospholipid scramblase 1 (PLSCR1). APLT is
known to regulate the amount of PS on the outer
membrane by aiding the return of externalized PS to
the inner membrane. A role for activation of
PLSCR1 in equilibrating phospholipids (PL) across
the membrane, and in particular enhancing PS
externalization is debatable. One report has sug-
gested that the main influential partner in PS
externalization, at least in FasL-mediated apoptosis,
is APLT, with PLSCR activation playing a minor
role.52 There is evidence that PLSCR1 is not
necessary for maintaining a difference in the
concentrations of PS in the internal and external
leaflets. In a recent mouse blood platelet study,
homozygous deletion of PLSCR failed to prevent PS
externalization.53
Our model system used a synthetic S-nitrosthiol-
based NO donor to release NO intracellularly.
Within cells, it has been suggested that NO is
available as an S-nitrosothiol store that is released in
a Ca2+-dependent manner, rather than by de novo
synthesis of NO by NOS.54 The mechanism of APLT
inhibition might be dependent on a transnitrosyla-
tion reaction, as opposed to a nitrosylation reaction.
The Ca2+-dependent release of NOmight give rise to
nitrosylating agents, such as N2O3, that react with
the active sites of cysteines of APLT, thereby
inhibiting the enzyme. In such an environment,
CRT could act as a source of Ca2+; moreover, the
direct interaction of CRT with various isoforms of
NOS has been shown to increase the catalytic
activity of the enzyme resulting in an increase in
NO bioavailability.7,8
Many proteins involved in inflammation and
cytoprotection are secreted by caspase-1-depen-
dent and non-dependent ‘unconventional’ proteinPlease cite this article as: Tarr, J. M., et al., A Mechanism of Release
doi:10.1016/j.jmb.2010.06.064secretion.55 Mature CRT lacks a leader sequence and
evidence from this study confirms secretion occurs
quickly after activation of cell stress and apoptosis,
at concentrations that cannot be accounted for by
necrosis (as monitored by lactate dehydrogenase
activity in our earlier study).22 CRT clearly has a
number of extracellular functions in tissue repair,17
angiogenesis56 and focal adhesion disassembly,30
and its extracellular expression might be by
unconventional means. Here, we report a mecha-
nism by which native CRT can be expressed on the
surface of cells. Importantly, it shows for the first
time a direct interaction of CRT and PS in a Ca2+-
dependent manner. When PS ‘flips’ to the cell
surface on inhibition of APLT by intracellular NO
release, it does so in a caspase 3-independent
manner and in association with CRT. The surface
expression of CRT is correlated precisely with this
process.
In summary, this study reveals a physiological
regulation of CRT release from cells that is redox-
based. Once released from cells, CRT has a role in
many physiological processes, including adhesion,
apoptotic cell clearance and tumor cell recognition.
Thus, this studydemonstrates, in part, that nitrosative
stress resulting in the nitrosylation of APLT causes
CRT externalization in associationwith PS, and hence
provides a partial explanation as to how CRT can be
released from cells in a manner that is not associated
with caspase-dependent apoptotic pathways.Materials and methods
Cell culture
Jurkat and HeLa cells were grown in RPMI-1640
medium and D-MEM medium, respectively, both supple-
mented with 10% (v/v) fetal calf serum and 1% penicillin
and 1% streptomycin.Bacterial strains and preparation of recombinant
full-length and N-C and P domains of calreticulin
Human CRT (1.2 kb) cDNA in pBluescript lacking the
leader sequence was amplified by PCR using the forward
primer:
5′-GAT CCT CGAGAGCCCGCCGTC TAC TTCAAG
GAG-3′
and the reverse primer:
5′-GAT CAA GCT TCT A CT ACA GCT CGT CCT CA
TGG CCT GGCC-3′
The forward primer contained a 5′ XhoI (C ⇓TC GAG)
restriction site and the anti-sense primer contained a 5′
HindIII (A ⇓AG CTT) cleavage site. The cDNA was
subcloned into XhoI and HindIII restriction sites of the
pET32 vector (Novagen, UK). An N-C-domain construct
that lacked the P-domain was made in a stepwise PCR/
ligation reaction using the pRSET (Invitrogen) vector as aof Calreticulin from Cells During Apoptosis, J. Mol. Biol. (2010),
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frame restriction sites that could be used in this restriction
strategy. First, the N-domain lacking the leader sequence
was amplified using the forward primer:
5′ -GATC CTC GGA GCC CGC CGT CTA CTT CAA
GGA G-3′
and the reverse primer:
5′-GATC CTG CAG TTC CAA GGA GCC GGA CTC
CAC CAC CTG-3′
This product, with a 5′ XhoI site and a 3′ PstI site (CTG
CA⇓G), was cloned into the respective sites in the pRSET
vector. The C-domain was then amplified using the
forward primer:
5′-GATC CTG CAG TAT GAT AAC TTT GGC GTG
CTG GGC-3′
and the reverse primer:
5′-GATCAAGCTT CTACAGCTCGTGTCCTTGGC
CTG GCC-3′
This product, containing a 5′ PstI site and a 3′ HindIII
site, was then cloned downstream of the N-domain in
pRSET. The complete NC cDNA was then amplified from
this carrier vector using the forward primer:
5′-GAT CCT CGG GAG CCC GCC GTC TAC TTC
AAG GAG-3′
and the reverse primer:
5′-GAT CAAGCT TCT ACAGCT CGTCCT TGGCCT
GGCC-3′
andwas ligated into the pET32b vector using the 5′XhoI and
3′ HindIII sites. Positive constructs, were selected by
restriction digestion with XhoI and HindIII. The P domain
was amplified from a pEGFP construct as a template using
the forward primer:
5′-GACT CTC GAG GAC GAT TGG GAC TTC CTG
CCA CCC AAG-3′
and the reverse primer:
5′-GATC AAG CTT GGC ATA GAC ACT GGG ATC
GGG AGA-3′
ligated into the pET32b vector using the 5′ SalI and 3′
HindIII restriction sites. The ligated constructs were all
transformed into BL21 (DE3)-R3/R Rosetta bacteria.
Colony scrapes of BL21(DE3)-R3/R Rosetta bacteria
transformed with CRT-pET32 constructs were inoculated
in 200 ml of LB + Amp (50 mg/ml) and incubated at 37 °C
in a shaking incubator until the cells were in log phase
with an optical density of 0.6 at 600 nm. The culture was
induced to generate protein by the addition of IPTG to
1 mM final concentration). Induced bacteria were incu-
bated at 37 °C for 2 h to allow accumulation of expressed
recombinant protein. The bacteria were then pelleted and
protein isolated as described.57Please cite this article as: Tarr, J. M., et al., A Mechanism of Release
doi:10.1016/j.jmb.2010.06.064For expression of full-length GFP-CRT, the CRT con-
structs were made with forward primer:
5′-GATC CTC GGG AGC CCG CCG TCT ACT TCA
AGG AG-3′
and reverse primer:
5′-GATCAAGCTTCTACAGCTCGTCCTTGGCCTG
GCC-3′
The construct was amplified using a pUC-CRT construct
reported earlier as a template.57 Constructs were cloned
into the pEGFP (BD Biosciences) and mammalian expres-
sion vectors and used for transient transfections. Control
constructs of GFP were transiently transfected into HeLa
cells using Lipofectamine™ 2000 (Invitrogen) according to
the manufacturer's instructions.58Induction of apoptosis in human cells
Apoptosis was induced in Jurkat cells by incubation with
25 ng/ml FasL for 4 h. The apoptotic status of cells was
assessed by annexin V/7-AAD staining, caspase 3 activation
and immunofluorescence analysis of nuclear fragmentation
and ER blebbing. HeLa cells (1×104 cells/well) were plated
in eight-well chamber slides and grown for 3 h at 37 °C.
Transient transfectionswere performedusing Lipofectamine
2000 according to the manufacturer's instructions.16,57
Briefly, HeLa cells were transfected with 1 μg of of GFP-
CRT cDNA. The cells were incubated overnight at 37 °C,
washed with PBS and then fed with DMEM (untreated) or
DMEM containing 1.0 mM H2O2 for 6 h.
Fluorescence microscopy
A Nikon TE2000U microscope (100× objective) with a
triple fluorescence filter wheel and equipped with a
Hamamatsu CCD camera, was used for image acquisition.
Deconvolution analysis was carried out using Openlab 4.4
software and figures were constructed using Adobe
Photoshop 5.5. Fluorescence imaging was achieved
using FITC-conjugated CRT, and PS was detected via its
binding to annexin V conjugated to phycoerythrin (PE).
We also used the GFP-CRT construct explained above, to
study the relocation of CRT in the presence and in the
absence of SNCEE.Subcellular fractionation and extracellular release of
endogenous CRT
Release of endogenous CRT from untreated FasL-
treated Jurkat cells was examined by detecting CRT in
the cell medium by immunoblotting using rabbit anti-
human CRT antisera (PA3-900, Affinity Bio-Reagents.
Untreated and FasL-treated Jurkat cells were exposed to
selected concentrations of digitonin that either permeabi-
lized the PM alone (0.005% (w/v) digitonin (50 μg/ml)) or
solubilized all membranes (0.05% (w/v) digitonin
(500 μg/ml)).34 The supernatants from the cell prepara-
tions were recovered. Supernatants from equal numbers of
cells corresponding to equal amounts of protein (30 μg)
were determined by the Bradford protein assay and by
nanodrop spectrophotometry (NanoDrop® ND-8000,
Nanodrop Technologies, DE). The protein fractions of
intact untreated cells, digitonin-permeabilized cells andof Calreticulin from Cells During Apoptosis, J. Mol. Biol. (2010),
12 Mechanisms of CRT Release from Cells Under Stressthe digitonin-release fractions were analyzed by SDS-
PAGE and immunoblotted with primary antibodies
against CRT, PDI, calnexin and KDEL. Peroxidase-labeled
secondary antibodies were detected by chemilumines-
cence with a Chemidoc™ imager (Bio-Rad Laboratories).
The relative amounts of CRT andmarker proteins released
from fully permeabilized cells or PM-alone permeabilized
cells were determined by densitometric analysis of the
digital images using Quantity One® software (Biorad).
Biotinylation and purification of cell-surface membrane
proteins
Surface proteins on resting and apoptotic HeLa and
Jurkat cells were biotinylated and isolated according to the
manufacturer's instructions (product no. 89881, Pierce).
Briefly, Jurkat cell types were grown and left unstressed or
treated with 25 ng/ml FasL for 4 h. For each set of
experimental conditions, cells at a concentration of 1×107/
ml were labeled with sulfo-NHS-biotin, a hydrophilic
reagent that cannot penetrate the plasma membrane. Cells
were added to lysis buffer at 4 °C and the cell lysates were
centrifuged at 10,000g for 2 min. Biotin-labeled external
plasma membrane proteins within the clarified superna-
tant were concentrated, affinity-purified, and eluted from
NeutrAvidin™ gel bead columns.
Immunoblot analysis
All protein samples were adjusted to equal concentra-
tions andwere subjected to reducing SDS-PAGE (10% (w/
v) polyacrylamide gels) in Tris–glycine buffer and blotted
onto polyvinylidene fluoride membranes in transblot
buffer (25 mMTris, 192 mM glycine, 10% (v/v) methanol).
Blots were blocked in 5% (w/v) milk powder in PBS/0.1%
(v/v) Tween 20 overnight and incubated with commercial
rabbit polyclonal antibodies against biotin (Abcam Ltd.,
ab34645), CRT (Affinity Bioreagents, PA3-900), PDI
(Stressgen, SPA-890) or commercial mouse monoclonal
anti-human antibodies against calnexin (Santa Cruz
Biotechnology, sc-46669), KDEL peptide (QED Bioscience
Inc., 11076-50), or Hsp70/Hsc70 HRP (Cambridge Bios-
ciences, SPA-757). Goat anti-mouse IgG-HRP (Santa Cruz,
sc2060) and goat anti-rabbit IgG HRP (Santa Cruz, sc2054)
were used as secondary antibodies. Chemiluminescence
signal detection of the targeted proteins was done with an
ECL substrate and imageswere capturedwith a Chemidoc
XS imager (Bio-Rad).
Interaction of FITC-CRT with lipids
Multilammelar liposomes were generated from either
pure 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine or
from a mixture of 70% 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine and 30% 1-palmitoyl-2-oleoyl-sn-glycero-
3-phospho-L-serine (Avanti Polar Lipids Inc.). Lipid
mixtures were made from 10 mg/ml stock solutions in
chloroform and stored at –20 °C. All pieces of apparatus
used to prepare the liposomes were cleaned and sterilized
by immersion in an ultrasound bath in water, autoclaved,
then immersed in an ultrasound bath in ethanol and finally
rinsed ten times in chloroform. The liposome mixture was
drawn into a Hamilton syringe and five drops (∼200 μl) of
solution were spread gently onto the roughened side of a
small Teflon plate (approximately 1 cm2) using the syringe
needle. The Teflon plate was then placed into a small glass
bottle, with the roughened side of the plate face up. The
bottle was placed into a vacuum desiccator and a smallPlease cite this article as: Tarr, J. M., et al., A Mechanism of Release
doi:10.1016/j.jmb.2010.06.064piece of filter paper was placed on top of the bottle, which
remained in the desiccator overnight to allow all the
chloroform evaporate. The bottle was removed from the
desiccator and 40 μl of ultrapure sterile water was gently
placed next to the Teflon plate in the bottle, ensuring the
water did not go onto the top face of the Teflon platewhere
the lipids were. The bottle was sealed and placed in an
oven at 37 °C for 2 h to allow the lipids to rehydrate. The
swelling solution was either 0.1 M sucrose, 10 mM Hepes,
140 mMNaCl and 2.5 mMCaC12, pH 7.4 for incubation in
the presence of Ca2+, or 0.1 M sucrose, 10 mM Hepes,
140 mM NaCl, 5 mM EGTA, pH 7.4 for incubation in the
absence of free Ca2+. The swelling solution was degassed
and incubated at 37 °C for 2 h. The bottle was removed and
2 ml of the swelling solution was passed gently down the
side of the bottle onto the Teflon plate, ensuring that the
lipids were not washed off. The bottle was sealed and
incubated at 37 °C for 48 h, whereupon the liposomes
formed and were ready for use.
Human full-length recombinant CRT, along with the N-
C domain and P domain of CRT, were conjugated to FITC,
using the fluorotag FITC conjugation procedure (Sigma,
Dorset, UK). The ratio of mol FITC bound/mol CRT was
determined to be approximately 3:1. Then various con-
centrations of lipids and annexin V-PE or CRT-FITC were
incubated as described in Results.Synthesis of SNCEE, cell treatment with SNCEE and
measurement of caspase 3 activation
SNCEE was prepared as described.24 Jurkat cells or
HeLa cells were incubated for 30 min at 37 °C in medium
alone, or treated with 600 μM SNCEE or treated with
600 μM SNCEE, 5 mM DTT. The caspase 3 activity assay
was done with the CaspACE™ assay system (Promega)
according to the manufacturer's instructions. The assay
utilizes the caspase 3-specific substrate Ac-DEVD labeled
with the yellow-green fluorochrome 7-amino-4-methyl
coumarin (AMC). Briefly, Jurkat cells to be assessed for
caspase activation were untreated or exposed to SNCEE,
FasL or both. The cell preparations were then lysed,
centrifuged at 16,000g for 20 min at 4 °C. The supernatants
were collected and transferred to black-bottomed 96-well
plates to which Ac-DEVD-AMC was added. Caspase 3
activity was measured after incubation for 1 h at 37 °C
using a BMG labtech PHERAstar plate reader (Aylesbury,
UK) at an excitationwavelength of 360 nmand an emission
wavelength of 460 nm.Acknowledgements
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